ask="11.30"
ask_size="300"
average_daily_volume="220232"
bid="9.05"
bid_size="100"
book_value="2.66"
change="-0.11"
change_from_200_day_moving_average="1.39"
change_from_50_day_moving_average="0.72"
change_from_52_week_high="-1.13"
change_From_52_week_low="2.94"
change_in_percent="-1.09%"
close="9.94"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.30"
ebitda="-117.58M"
eps_estimate_current_year="-2.03"
eps_estimate_next_quarter="-0.30"
eps_estimate_next_year="-1.73"
ex_dividend_date="N/A"
float_shares="15522000"
high="10.24"
high_52_weeks="11.07"
last_trade_date="1/13/2017"
last_trade_price="9.94"
last_trade_size="7312"
last_trade_time="4:00pm"
low="9.86"
low_52_weeks="7.00"
market_capitalization="181.90M"
moving_average_200_day="8.55"
moving_average_50_day="9.22"
name="Akebia Therapeutics
Inc."
notes="N/A"
one_year_target_price="16.00"
open="10.11"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+16.26%"
percent_change_from_50_day_moving_average="+7.76%"
percent_change_from_52_week_high="-10.21%"
percent_change_from_52_week_low="+42.00%"
previous_close="10.05"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.78"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18300000"
short_ratio="13.24"
stock_exchange="NGM"
symbol="AKBA"
volume="190748"
weeks_range_52="7.00 - 11.07"
